7Baggers

Kiniksa Pharmaceuticals Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 027.4354.8782.3109.74137.17164.6192.04Milllion

Kiniksa Pharmaceuticals Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 
                               
  assets                             
  current assets:                             
  cash and cash equivalents192,037,000 157,132,000 183,581,000 97,376,000 99,271,000 141,078,000 107,954,000 117,828,000 112,567,000 80,618,000 122,715,000 175,761,000 94,307,000 63,324,000 122,470,000 190,183,000 167,953,000 119,856,000 114,038,000 85,874,000 123,456,000 106,336,000 46,928,000 68,809,000 82,810,000 82,629,000 71,976,000 69,663,000 285,518,000 
  short-term investments115,745,000 111,208,000 60,046,000 126,404,000 119,487,000 72,474,000 98,417,000 83,256,000 72,425,000 106,876,000 67,893,000 24,963,000 43,901,000 82,253,000 59,731,000 10,000,000 57,913,000 144,169,000 209,444,000 278,521,000 128,942,000 97,870,000 186,452,000 189,936,000 204,637,000 243,904,000 235,328,000 268,200,000 73,672,000 
  accounts receivable31,910,000 40,065,000 41,724,000 24,888,000 20,451,000 15,995,000 21,266,000 3,041,000 24,650,000 7,424,000 12,660,000 11,159,000 7,808,000 29,440,000 3,985,000 3,224,000 2,551,000             
  inventory48,181,000 22,069,000 26,364,000 28,680,000 34,858,000 27,278,000 31,122,000 25,583,000 23,958,000 23,425,000 21,599,000 14,621,000 19,916,000 13,223,000 3,675,000 5,606,000 6,381,000 2,189,000            
  prepaid expenses and other current assets32,438,000 25,433,000 20,084,000 33,953,000 26,954,000 13,766,000 17,538,000 26,401,000 12,440,000 13,157,000 10,537,000 15,311,000 14,006,000 10,517,000 6,585,000 8,499,000 9,802,000 9,140,000 9,557,000 14,018,000 12,095,000 8,849,000 8,247,000 9,595,000 9,011,000 8,423,000 6,446,000 3,665,000 4,416,000 
  total current assets420,311,000 355,907,000 331,799,000 311,301,000 301,021,000 270,591,000 276,297,000 256,109,000 246,040,000 231,500,000 243,060,000 241,815,000 179,938,000 198,757,000 196,446,000 217,512,000 244,810,000 275,564,000 333,249,000 378,413,000 264,493,000 213,055,000 241,627,000 268,340,000 296,458,000 334,956,000 313,750,000 341,528,000 363,869,000 
  property and equipment1,076,000 606,000 662,000 561,000 625,000 712,000 734,000 918,000 1,136,000 1,393,000 1,658,000 1,995,000 2,150,000 2,475,000 2,834,000 3,168,000 3,449,000 3,815,000 4,051,000 4,573,000 5,210,000 5,804,000 6,398,000 6,409,000 6,359,000 6,190,000 6,356,000 2,360,000 350,000 
  operating lease right-of-use assets10,304,000 10,453,000 10,376,000 11,095,000 11,779,000 12,324,000 11,931,000 12,668,000 13,191,000 5,228,000 5,385,000 6,173,000 4,069,000 4,815,000 5,550,000 6,128,000 5,386,000 5,982,000 6,566,000 1,166,000 1,323,000 1,629,000 1,927,000 2,218,000 2,503,000 3,347,000    
  other long-term assets8,195,000 8,202,000 10,315,000 7,853,000 7,904,000 4,128,000 827,000 2,294,000 2,353,000 2,323,000 5,824,000 5,627,000 5,669,000 5,918,000 8,720,000 6,551,000 5,813,000 5,797,000 5,588,000 48,000          
  intangible asset15,750,000 16,000,000 16,250,000 16,500,000 16,750,000 17,000,000 17,250,000 17,500,000 17,750,000 18,000,000 18,250,000 18,500,000 18,750,000 19,000,000 19,250,000 19,500,000 19,750,000 20,000,000            
  deferred tax assets205,514,000 208,158,000 211,151,000 207,988,000 204,349,000 214,918,000 219,283,000 193,574,000 203,862,000 184,418,000 185,495,000 185,843,000       10,000 3,000  5,410,000 4,372,000 4,628,000 2,607,000 1,456,000 1,216,000 1,173,000 700,000 
  total assets661,150,000 599,326,000 580,553,000 555,298,000 542,428,000 519,673,000 526,322,000 483,063,000 484,332,000 442,862,000 459,672,000 459,953,000 210,576,000 230,965,000 232,800,000 252,859,000 279,208,000 311,158,000 349,464,000 384,413,000 271,441,000 226,108,000 254,534,000 281,805,000 308,137,000 346,159,000 321,965,000 347,101,000 365,129,000 
  ​                             
  liabilities and shareholders’ equity                             
  current liabilities:                             
  accounts payable8,956,000 1,982,000 2,039,000 8,328,000 7,393,000 5,632,000 8,246,000 1,012,000 648,000 1,391,000 7,899,000 1,469,000 2,522,000 3,383,000 1,868,000 1,649,000 4,156,000 2,763,000 503,000 3,925,000 2,373,000 4,274,000 5,693,000 6,440,000 9,338,000 6,890,000 10,918,000 4,668,000 561,000 
  accrued collaboration expenses52,389,000 53,775,000 48,157,000 29,148,000 29,943,000                         
  accrued expenses35,959,000 22,126,000 32,355,000 40,379,000 33,374,000 44,718,000 44,667,000 41,149,000 35,316,000 20,885,000 30,112,000 30,868,000 34,500,000 38,887,000 38,031,000 28,528,000 31,064,000 30,316,000 29,199,000 19,475,000 16,499,000 13,379,000 20,415,000 19,360,000 19,179,000 15,618,000 16,418,000 13,353,000 12,583,000 
  operating lease liabilities2,522,000 2,292,000 1,993,000 2,031,000 2,085,000 2,279,000 2,253,000 2,313,000 2,238,000 3,482,000 3,301,000 3,274,000 3,336,000 3,311,000 3,381,000 3,246,000 2,636,000 2,374,000 2,107,000 1,492,000 1,680,000 1,689,000 1,697,000 1,610,000 1,496,000 1,384,000    
  other current liabilities18,001,000 17,092,000 16,077,000 16,069,000 11,484,000 11,427,000 8,193,000 6,430,000 4,596,000 4,334,000 5,754,000 8,789,000 3,186,000 4,773,000 1,544,000 1,004,000 926,000  37,000    25,000  165,000  218,000   
  total current liabilities117,827,000 97,267,000 100,621,000 95,955,000 84,291,000 64,212,000 63,666,000 53,468,000 47,472,000 36,587,000 47,066,000 56,492,000 43,544,000 50,354,000 44,824,000 34,427,000 38,782,000 35,453,000 31,846,000 24,892,000 20,552,000 19,342,000 27,830,000 27,560,000 30,178,000 36,892,000 42,554,000 28,021,000 23,144,000 
  non-current liabilities:                             
  non-current deferred revenue31,811,000 31,811,000 31,811,000 11,811,000 11,799,000 11,811,000 11,954,000 11,872,000 12,006,000 12,163,000 12,000,000 14,198,000                  
  non-current operating lease liabilities7,243,000 7,623,000 7,862,000 8,564,000 9,317,000 9,864,000 10,005,000 10,651,000 11,283,000 2,133,000 2,618,000 3,435,000 1,278,000 2,096,000 2,669,000 3,499,000 3,500,000 4,200,000 4,878,000 55,000 139,000 551,000        
  other long-term liabilities9,262,000 5,136,000 1,823,000 1,962,000 1,926,000 1,891,000 1,858,000 1,945,000 1,915,000 1,884,000 1,839,000 1,820,000 260,000 271,000 270,000 885,000 1,141,000 809,000 805,000 957,000 334,000 381,000 326,000 943,000 943,000 509,000    
  total liabilities166,143,000 141,837,000 142,117,000 118,292,000 107,333,000 87,778,000 87,483,000 77,936,000 72,676,000 52,767,000 63,523,000 75,945,000 57,082,000 64,721,000 47,763,000 38,811,000 43,423,000 40,462,000 37,529,000 25,904,000 21,025,000 20,274,000 29,111,000 29,894,000 32,940,000 39,640,000 42,698,000 28,188,000 23,330,000 
  commitments and contingencies                             
  shareholders’ equity:                             
  class a ordinary shares, nominal value of 0.000273235 per share; 43,397,623 shares and 41,881,319 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively12,000                             
  class b ordinary shares, nominal value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of june 30, 2025 and december 31, 20241,000                             
  class a1 ordinary shares, nominal value of 0.000273235 per share; 12,781,964 shares issued and outstanding as of june 30, 2025 and december 31, 20244,000                             
  class b1 ordinary shares, 0.000273235 nominal value; 16,057,618 shares issued and outstanding as of june 30, 2025 and december 31, 20244,000                             
  additional paid-in capital989,811,000 970,238,000 959,722,000 949,282,000 934,767,000 927,582,000 916,763,000 908,295,000 900,956,000 894,325,000 888,120,000 880,554,000 874,153,000 866,935,000 860,482,000 853,139,000 844,260,000 837,656,000 829,424,000 822,301,000 670,371,000 588,090,000 581,467,000 576,129,000 572,318,000 566,542,000 473,483,000 470,600,000 469,018,000 
  accumulated other comprehensive loss-53,000 -165,000          -70,000 -90,000 -103,000 -66,000   -21,000            
  accumulated deficit-494,772,000 -512,604,000 -521,143,000 -512,255,000 -499,562,000 -495,654,000 -477,950,000 -503,187,000 -489,332,000 -504,304,000 -492,034,000 -496,495,000 -720,588,000 -700,607,000 -675,397,000 -639,064,000 -608,520,000 -566,957,000 -517,473,000 -463,816,000 -419,980,000 -382,511,000 -356,092,000 -324,295,000 -297,237,000 -260,046,000 -194,225,000 -151,645,000  
  total shareholders’ equity495,007,000 457,489,000 438,436,000 437,006,000 435,095,000 431,895,000 438,839,000 405,127,000 411,656,000 390,095,000 396,149,000 384,008,000 153,494,000 166,244,000 185,037,000 214,048,000 235,785,000 270,696,000 311,935,000 358,509,000 250,416,000 205,834,000 225,423,000 251,911,000 275,197,000 306,519,000 279,267,000 318,913,000 341,799,000 
  total liabilities and shareholders’ equity661,150,000 599,326,000 580,553,000 555,298,000 542,428,000 519,673,000 526,322,000 483,063,000 484,332,000 442,862,000 459,672,000 459,953,000 210,576,000 230,965,000 232,800,000 252,859,000 279,208,000 311,158,000 349,464,000 384,413,000 271,441,000 226,108,000 254,534,000 281,805,000 308,137,000 346,159,000    
  class a ordinary shares, nominal value of 0.000273235 per share; 42,162,592 shares and 41,881,319 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively 11,000                            
  class b ordinary shares, nominal value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of march 31, 2025 and december 31, 2024 1,000                            
  class a1 ordinary shares, nominal value of 0.000273235 per share; 12,781,964 shares issued and outstanding as of march 31, 2025 and december 31, 2024 4,000                            
  class b1 ordinary shares, 0.000273235 nominal value; 16,057,618 shares issued and outstanding as of march 31, 2025 and december 31, 2024 4,000                            
  deferred revenue    12,000 156,000 307,000 2,564,000 4,674,000 6,495,000  12,092,000 12,000,000 12,000,000                
  class a ordinary shares, par value of 0.000273235 per share; 41,881,319 shares and 35,781,373 shares issued and outstanding as of december 31, 2024 and 2023, respectively  11,000                           
  class b ordinary shares, par value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of december 31, 2024 and 2023  1,000                           
  class a1 ordinary shares, 0.000273235 par value; 12,781,964 shares and 16,826,468 issued and outstanding as of december 31, 2024 and 2023, respectively  4,000                           
  class b1 ordinary shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2024 and 2023  4,000                           
  accumulated other comprehensive income  -163,000 -41,000 -130,000 -53,000 6,000 -1,000 13,000 55,000 44,000     -45,000 27,000  -34,000 6,000 9,000 240,000 33,000 62,000 101,000 8,000  -55,000 7,000 
  class a ordinary shares, nominal value of 0.000273235 per share; 41,523,449 shares and 35,781,373 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively   11,000                          
  class b ordinary shares, nominal value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of september 30, 2024 and december 31, 2023   1,000                          
  class a1 ordinary shares, 0.000273235 nominal value; 12,781,964 and 16,826,468 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively   4,000                          
  class b1 ordinary shares, 0.000273235 nominal value; 16,057,618 shares issued and outstanding as of september 30, 2024 and december 31, 2023   4,000                          
  class a ordinary shares, nominal value of 0.000273235 per share; 40,447,538 shares and 35,781,373 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively    11,000                         
  class b ordinary shares, nominal value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of june 30, 2024 and december 31, 2023    1,000                         
  class a1 ordinary shares, 0.000273235 nominal value; 12,781,964 and 16,826,468 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively    4,000                         
  class b1 ordinary shares, 0.000273235 nominal value; 16,057,618 shares issued and outstanding as of june 30, 2024 and december 31, 2023    4,000                         
  class a common shares, par value of 0.000273235 per share; 40,184,356 shares and 35,781,373 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively     11,000                        
  class b common shares, par value of 0.000273235 per share; 1,795,158 shares issued and outstanding as of march 31, 2024 and december 31, 2023     1,000                        
  class a1 common shares, 0.000273235 par value; 12,781,964 and 16,826,468 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively     4,000                        
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of march 31, 2024 and december 31, 2023     4,000                        
  contract asset          7,656,000                   
  class a common shares, par value of 0.000273235 per share; 35,781,373 shares and 34,750,560 shares issued and outstanding as of december 31, 2023 and 2022, respectively      10,000                       
  class b common shares, par value of 0.000273235 per share; 1,795,158 shares and 1,813,457 shares issued and outstanding as of december 31, 2023 and 2022, respectively      1,000                       
  class a1 common shares, 0.000273235 par value; 16,826,468 shares and 17,075,868 issued and outstanding as of december 31, 2023 and 2022, respectively      5,000                       
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2023 and 2022      4,000                       
  class a common shares, par value of 0.000273235 per share; 35,387,987 shares and 34,750,560 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively       10,000                      
  class b common shares, par value of 0.000273235 per share; 1,795,158 shares and 1,813,457 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively       1,000                      
  class a1 common shares, 0.000273235 par value; 17,075,868 shares issued and outstanding as of september 30, 2023 and december 31, 2022       5,000                      
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of september 30, 2023 and december 31, 2022       4,000                      
  class a common shares, par value of 0.000273235 per share; 35,074,019 shares and 34,750,560 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively        9,000                     
  class b common shares, par value of 0.000273235 per share; 1,795,158 shares and 1,813,457 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively        1,000                     
  class a1 common shares, 0.000273235 par value; 17,075,868 shares issued and outstanding as of june 30, 2023 and december 31, 2022        5,000                     
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of june 30, 2023 and december 31, 2022        4,000                     
  class a common shares, par value of 0.000273235 per share; 34,886,136 shares and 34,750,560 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively         9,000                    
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares issued and outstanding as of march 31, 2023 and december 31, 2022         1,000                    
  class a1 common shares, 0.000273235 par value; 17,075,868 shares issued and outstanding as of march 31, 2023 and december 31, 2022         5,000                    
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of march 31, 2023 and december 31, 2022         4,000                    
  class a common shares, par value of 0.000273235 per share; 34,750,560 shares and 34,059,725 shares issued and outstanding as of december 31, 2022 and 2021, respectively          9,000                   
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares issued and outstanding as of december 31, 2022 and 2021          1,000                   
  class a1 common shares, 0.000273235 par value; 17,075,868 shares and 17,129,603 issued and outstanding as of december 31, 2022 and 2021, respectively          5,000                   
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2022 and 2021          4,000                   
  class a common shares, par value of 0.000273235 per share; 34,523,660 shares and 34,059,725 shares issued and outstanding as of september 30, 2022 and december 31, 2021, respectively           9,000                  
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares issued and outstanding as of september 30, 2022 and december 31, 2021           1,000                  
  class a1 common shares, 0.000273235 par value; 17,129,603 shares issued and outstanding as of september 30, 2022 and december 31, 2021           5,000                  
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of september 30, 2022 and december 31, 2021           4,000                  
  class a common shares, par value of 0.000273235 per share; 34,426,089 shares and 34,059,725 shares issued and outstanding as of june 30, 2022 and december 31, 2021, respectively            9,000                 
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares issued and outstanding as of june 30, 2022 and december 31, 2021            1,000                 
  class a1 common shares, 0.000273235 par value; 17,129,603 shares issued and outstanding as of june 30, 2022 and december 31, 2021            5,000                 
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of june 30, 2022 and december 31, 2021            4,000                 
  class a common shares, par value of 0.000273235 per share; 34,270,445 shares and 34,059,725 shares issued and outstanding as of march 31, 2022 and december 31, 2021, respectively             9,000                
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares issued and outstanding as of march 31, 2022 and december 31, 2021             1,000                
  class a1 common shares, 0.000273235 par value; 17,129,603 shares issued and outstanding as of march 31, 2022 and december 31, 2021             5,000                
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of march 31, 2022 and december 31, 2021             4,000                
  restricted cash                210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000   263,000 
  class a common shares, par value of 0.000273235 per share; 34,059,725 shares and 31,777,420 shares issued and outstanding as of december 31, 2021 and 2020, respectively              8,000               
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares and 2,355,458 shares issued and outstanding as of december 31, 2021 and 2020, respectively              1,000               
  class a1 common shares, 0.000273235 par value; 17,129,603 shares and 18,024,526 issued and outstanding as of december 31, 2021 and 2020, respectively              5,000               
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2021 and 2020              4,000               
  class a common shares, par value of 0.000273235 per share; 32,992,834 shares and 31,777,420 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively               8,000              
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares and 2,355,458 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively               1,000              
  class a1 common shares, 0.000273235 par value; 18,024,526 issued and outstanding as of september 30, 2021 and december 31, 2020               5,000              
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of september 30, 2021 and december 31, 2020               4,000              
  class a common shares, par value of 0.000273235 per share; 32,569,148 shares and 31,777,420 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively                8,000             
  class b common shares, par value of 0.000273235 per share; 1,813,457 shares and 2,355,458 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively                1,000             
  class a1 common shares, 0.000273235 par value; 18,024,526 issued and outstanding as of june 30, 2021 and december 31, 2020                5,000             
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of june 30, 2021 and december 31, 2020                4,000             
  class a common shares, par value of 0.000273235 per share; 32,320,276 shares and 31,777,420 shares issued and outstanding as of march 31, 2021 and december 31, 2020, respectively                 8,000            
  class b common shares, par value of 0.000273235 per share; 1,927,614 shares and 2,355,458 shares issued and outstanding as of march 31, 2021 and december 31, 2020, respectively                 1,000            
  class a1 common shares, 0.000273235 par value; 18,024,526 issued and outstanding as of march 31, 2021 and december 31, 2020                 5,000            
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of march 31, 2021 and december 31, 2020                 4,000            
  non-current restricted cash                             
  class a common shares, par value of 0.000273235 per share; 31,777,420 shares and 19,245,201 shares issued and outstanding as of december 31, 2020 and 2019, respectively                  8,000           
  class b common shares, par value of 0.000273235 per share; 2,355,458 shares and 4,638,855 shares issued and outstanding as of december 31, 2020 and 2019, respectively                  1,000           
  class a1 common shares, 0.000273235 par value; 18,024,526 shares and 14,995,954 issued and outstanding as of december 31, 2020 and 2019, respectively                  5,000           
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2020 and 2019                  4,000           
  class a common shares, par value of 0.000273235 per share; 31,479,648 shares and 19,245,201 shares issued and outstanding as of september 30, 2020 and december 31, 2019, respectively                   8,000          
  class b common shares, par value of 0.000273235 per share; 2,355,458 shares and 4,638,855 shares issued and outstanding as of september 30, 2020 and december 31, 2019, respectively                   1,000          
  class a1 common shares, 0.000273235 par value; 18,024,526 shares and 14,995,954 issued and outstanding as of september 30, 2020 and december 31, 2019, respectively                   5,000          
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of september 30, 2020 and december 31, 2019                   4,000          
  deferred offering costs                    205,000      433,000   
  class a common shares, par value of 0.000273235 per share; 25,369,973 shares and 19,245,201 shares issued and outstanding as of june 30, 2020 and december 31, 2019, respectively                    7,000         
  class b common shares, par value of 0.000273235 per share; 2,463,011 shares and 4,638,855 shares issued and outstanding as of june 30, 2020 and december 31, 2019                    1,000         
  class a1 common shares, 0.000273235 par value; 16,595,954 shares and 14,995,954 issued and outstanding as of june 30, 2020 and december 31, 2019, respectively                    4,000         
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of june 30, 2020 and december 31, 2019                    4,000         
  class a common shares, par value of 0.000273235 per share; 21,519,500 shares and 19,245,201 shares issued and outstanding as of march 31, 2020 and december 31, 2019, respectively                     6,000        
  class b common shares, par value of 0.000273235 per share; 3,008,373 shares and 4,638,855 shares issued and outstanding as of march 31, 2020 and december 31, 2019                     1,000        
  class a1 common shares, 0.000273235 par value; 14,995,954 shares issued and outstanding as of march 31, 2020 and december 31, 2019, respectively                     4,000        
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of march 31, 2020 and december 31, 2019                     4,000        
  accrued milestones                       150,000  13,000,000 15,000,000   
  noncurrent liabilities:                             
  noncurrent operating lease liabilities                      955,000 1,391,000 1,819,000 2,239,000    
  class a common shares, par value of 0.000273235 per share; 19,245,201 shares and 15,797,220 shares issued and outstanding as of december 31, 2019 and december 31, 2018, respectively                      6,000       
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares issued and outstanding as of december 31, 2019 and december 31, 2018                      1,000       
  class a1 common shares, 0.000273235 par value; 14,995,954 and 12,995,954 shares issued and outstanding as of december 31, 2019 and december 31, 2018, respectively                      4,000       
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of december 31, 2019 and december 31, 2018                      4,000       
  class a common shares, par value of 0.000273235 per share; 19,178,913 shares and 15,797,220 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively                       6,000      
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares issued and outstanding as of september 30, 2019 and december 31, 2018                       1,000      
  class a1 common shares, 0.000273235 par value; 14,995,954 shares and 12,995,954 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively                       4,000      
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of september 30, 2019 and december 31, 2018                       4,000      
  class a common shares, par value of 0.000273235 per share; 19,165,265 shares and 15,797,220 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively                        6,000     
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares issued and outstanding as of june 30, 2019 and december 31, 2018                        1,000     
  class a1 common shares, 0.000273235 par value; 14,995,954 shares and 12,995,954 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively                        4,000     
  class b1 common shares, 0.000273235 par value; 16,057,618 shares issued and outstanding as of june 30, 2019 and december 31, 2018                        4,000     
  class a common shares, par value of 0.000273235 per share; 19,000,408 shares and 15,797,220 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively                         6,000    
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares and 4,638,855 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively                         1,000    
  class a1 common shares, 0.000273235 par value; 14,995,954 shares and 12,995,954 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively                         4,000    
  class b1 common shares, 0.000273235 par value; 16,057,618 shares and 16,057,618 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively                         4,000    
  liabilities, convertible preferred shares and shareholders’ equity                             
  deferred rent                          144,000 167,000 186,000 
  convertible preferred shares (series a, b and c), 0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of december 31, 2018 and december 31, 2017, respectively; aggregate liquidation preference of 0 and 120,000 as of december 31, 2018 and december 31, 2017, respectively;                             
  shareholders’ equity                             
  class a common shares, par value of 0.000273235 per share; 15,797,220 shares and 719,976 shares issued and outstanding as of december 31, 2018 and december 31, 2017; respectively                          4,000   
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares and 3,568,353 shares issued and outstanding as of december 31, 2018 and december 31, 2017, respectively                          1,000   
  class a1 common shares, 0.000273235 par value; 12,995,954 shares and 0 shares issued and outstanding as of december 31, 2018 and december 31, 2017, respectively                          4,000   
  class b1 common shares, 0.000273235 par value; 16,057,618 shares and 0 shares issued and outstanding as of december 31, 2018 and december 31, 2017, respectively                          4,000   
  total liabilities, convertible preferred shares and shareholders’ equity                          321,965,000 347,101,000 365,129,000 
  advanced clinical payments                           1,830,000  
  accrued milestone                           10,000,000 10,000,000 
  convertible preferred shares (series a, b and c), 0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively; aggregate liquidation preference of 0 and 120,000 as of september 30, 2018 and december 31, 2017, respectively;                             
  class a common shares, par value of 0.000273235 per share; 15,772,257 shares and 719,976 shares issued and outstanding as of september 30, 2018 and december 31, 2017; respectively                           4,000  
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares and 3,568,353 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively                           1,000  
  class a1 common shares, 0.000273235 par value; 12,995,954 shares and 0 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively                           4,000  
  class b1 common shares, 0.000273235 par value; 16,057,618 shares and 0 shares issued and outstanding as of september 30, 2018 and december 31, 2017, respectively                           4,000  
  convertible preferred shares (series a, b and c), 0.000273235 par value; 0 shares and 22,885,492 shares issued and outstanding as of june 30, 2018 and december 31, 2017, respectively; aggregate liquidation preference of 0 and 120,000 as of june 30, 2018 and december 31, 2017, respectively;                             
  class a common shares, par value of 0.000273235 per share; 15,754,771 shares and 719,976 shares issued and outstanding as of june 30, 2018 and december 31, 2017; respectively                            4,000 
  class b common shares, par value of 0.000273235 per share; 4,638,855 shares and 3,568,353 shares issued and outstanding as of june 30, 2018 and december 31, 2017, respectively                            1,000 
  class a1 common shares, 0.000273235 par value; 12,995,954 shares and 0 shares issued and outstanding as of june 30, 2018 and december 31, 2017, respectively                            4,000 
  class b1 common shares, 0.000273235 par value; 16,057,618 shares and 0 shares issued and outstanding as of june 30, 2018 and december 31, 2017, respectively                            4,000 

We provide you with 20 years of balance sheets for Kiniksa Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kiniksa Pharmaceuticals. Explore the full financial landscape of Kiniksa Pharmaceuticals stock with our expertly curated balance sheets.

The information provided in this report about Kiniksa Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.